ArticleJournal of experimental & clinical cancer research : CR2023

Interleukin-30 subverts prostate cancer-endothelium crosstalk by fostering angiogenesis and activating immunoregulatory and oncogenic signaling pathways.

Stefania Livia Ciummo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.